Prognosis of myelomatosis on treatment with prednisone and cytostatics.
D000368:Aged; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004590:Electrophoresis, Paper; D005260:Female; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D008297:Male; D008558:Melphalan / Q000627:therapeutic use*; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000188:drug therapy / Q000401:mortality*; D009194:Myeloma Proteins / Q000097:blood*; D011241:Prednisone / Q000627:therapeutic use*; D011379:Prognosis; D012737:Sex Factors; D013997:Time Factors
D007070:Immunoglobulin A; D007074:Immunoglobulin G; D009194:Myeloma Proteins; D003520:Cyclophosphamide; D008558:Melphalan; D011241:Prednisone